colloidal silver
Small moleculemarketed
Approved
Jan 1, 1899
The medical uses of silver include its use in wound dressings, creams, and as an antibiotic coating on medical devices. Wound dressings containing silver sulfadiazine or silver nanomaterials may be used to treat external infections. The limited evidence available shows that silver coatings on endotracheal breathing tubes may reduce the incidence of ventilator-associated pneumonia. There is tentative evidence that using silver-alloy indwelling catheters for short-term catheterizing will reduce the risk of catheter-acquired urinary tract infections. — Wikipedia
Clinical trial activity
13 trials · 12 clinical orgs · 0 marketing orgs
Phase 1
5
Phase 2
4
Phase 3
1
Phase 4
2
Earliest trial started Dec 1, 2010 (NCT01243320)
Timeline
Indications
Approved for
Mechanism of action
- Unspecified targetUnclear
unclear
Approval history
- approvedJan 1, 1899
Chemistry & pharmacology
Loading structure…
SMILES
[Ag+]- Mol. weight
- 107.87 g/mol
- Chirality
- Achiral Molecule
- Inorganic
- Yes
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaMedical uses of silver ↗
- ChEMBLCHEMBL1230866 ↗
Also known as
- argentum metallicum
- collargol
- colloidal silver
- colloidal silver
- colloidal silver
- colloidal silver
- colloidal silver
- e174
- e174
- nanosilver
- nanosilver
- silver
- silver
- silver
- silver
- silver
- silver colloid
- silver colloid
- silver colloidal
- silver, colloidal
- silver, colloidal
- silver microparticles
- silver nanoparticles
- silver nanoparticles
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07200063 | N/A | Jan 31, 2026 | Cairo University |
| NCT05850819 | N/A | Jul 1, 2022 | Melaka Manipal Medical College |
| NCT05255913 | N/A | Mar 31, 2022 | Alexandria University |
| NCT05206578 | Phase 3 | Dec 8, 2020 | Ahn-Gook Pharmaceuticals Co.,Ltd |
| NCT04978025 | N/A | Nov 1, 2020 | Hôpital Universitaire Sahloul |
| NCT03692286 | Phase 4 | Oct 15, 2018 | Cairo University |
| NCT03243201 | Phase 1 | Jan 31, 2018 | Washington University in St. Louis |
| NCT02584153 | Phase 1 | Jul 1, 2017 | University of California, San Francisco |
| NCT02581488 | Phase 4 | Oct 1, 2015 | Smith & Nephew |
| NCT02403479 | Phase 1/Phase 2 (Phase 2) | Sep 1, 2015 | Schulich School of Medicine and Dentistry, University of Western Ontario |
| NCT02652169 | N/A | Jun 1, 2014 | University of Vienna |
| NCT01405794 | Phase 1/Phase 2 (Phase 2) | Jul 1, 2011 | University of Utah |
| NCT01243320 | Phase 1/Phase 2 (Phase 2) | Dec 1, 2010 | University of Utah |
Showing 13 of 13 trials
Page 1 / 1
Organizations
Research & Development (12)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Cairo University | Academic/Hospital | 2 | 2 | 2 | 2018 |
| University of Utah | Academic/Hospital | 2 | 2 | 1 | 2010 |
| Ahn-Gook Pharmaceuticals Co.,Ltd | For profit | 1 | 1 | 1 | 2020 |
| Alexandria University | Academic/Hospital | 1 | 1 | 1 | 2022 |
| Hôpital Universitaire Sahloul | Academic/Hospital | 1 | 1 | 1 | 2020 |
| Melaka Manipal Medical College | Academic/Hospital | 1 | 1 | 1 | 2022 |
| Schulich School of Medicine and Dentistry | Academic/Hospital | 1 | 0 | 1 | 2015 |
| Smith & Nephew | For profit | 1 | 1 | 1 | 2015 |
| University of California, San Francisco | Academic/Hospital | 1 | 1 | 1 | 2017 |
| University of Vienna | Academic/Hospital | 1 | 1 | 1 | 2014 |
| University of Western Ontario | Academic/Hospital | 1 | 1 | 1 | 2015 |
| Washington University in St. Louis | Academic/Hospital | 1 | 1 | 1 | 2018 |
12 organizations
Page 1 / 1